Skip to main content
Michael Macklin, MD, Rheumatology, Chicago, IL

MichaelMacklinMDPharmD

Rheumatology Chicago, IL

Assistant Professor of Medicine

Dr. Macklin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Macklin's full profile

Already have an account?

  • Office

    5841 S Maryland Ave
    Chicago, IL 60637
    Phone+1 773-702-6119
    Fax+1 773-702-8702

Summary

  • I am junior faculty at the University of Chicago, leading the development of a new multidisciplinary scleroderma clinic. My interests include scleroderma, ILD, vasculitis and medical education.

Education & Training

  • University of Chicago
    University of ChicagoFellowship, Rheumatology, 2022 - 2024
  • UPMC Medical Education
    UPMC Medical EducationResidency, Internal Medicine, 2019 - 2022
  • University of Pittsburgh School of Medicine
    University of Pittsburgh School of MedicineClass of 2019
  • Albany College of Pharmacy and Health Sciences
    Albany College of Pharmacy and Health Sciences PharmD, Magna Cum Laude, 2009 - 2015

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2022 - 2026
  • IN State Medical License
    IN State Medical License 2024 - 2025
  • PA State Medical License
    PA State Medical License 2019 - 2022
  • American Board of Internal Medicine Internal Medicine

Publications & Presentations

PubMed

Journal Articles

  • Checkpoint Inhibitor-Associated Scleroderma and Scleroderma Mimics  
    Macklin, M.; Yadav, S.; Jan, R.; Reid, P., Pharmaceuticals, 2/8/2023
  • Giant Cell Arteritis: Does Perivascular Inflammation on Biopsy Lead to Clinical Disease?  
    Macklin, M., Zarbalian, Y., Wang, L., Hamilton, R., & Liang, K., Journal of Advances in Medicine and Medical Research, 3/9/2002